Annual Revenue
$60.00 K
-$390.00 K-86.67%
31 December 2023
Summary:
Yield10 Bioscience annual revenue is currently $60.00 thousand, with the most recent change of -$390.00 thousand (-86.67%) on 31 December 2023. During the last 3 years, it has fallen by -$739.00 thousand (-92.49%). YTEN annual revenue is now -99.86% below its all-time high of $41.38 million, reached on 31 December 2012.YTEN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$450.00 K
+$150.00 K+50.00%
30 June 2024
Summary:
Yield10 Bioscience quarterly revenue is currently $450.00 thousand, with the most recent change of +$150.00 thousand (+50.00%) on 30 June 2024. YTEN quarterly revenue is now -98.86% below its all-time high of $39.32 million, reached on 31 March 2012.YTEN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$810.00 K
+$450.00 K+125.00%
30 June 2024
Summary:
Yield10 Bioscience TTM revenue is currently $810.00 thousand, with the most recent change of +$450.00 thousand (+125.00%) on 30 June 2024. YTEN TTM revenue is now -98.04% below its all-time high of $41.38 million, reached on 31 December 2012.YTEN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -86.7% | - | - |
3 y3 years | -92.5% | +389.1% | +23.3% |
5 y5 years | -89.2% | +100.9% | +1.1% |
YTEN Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -92.5% | at low | at high | +650.0% | at high | +1250.0% |
5 y | 5 years | -92.6% | at low | at high | +650.0% | -5.9% | +1250.0% |
alltime | all time | -99.9% | at low | -98.9% | +1400.0% | -98.0% | +1250.0% |
Yield10 Bioscience Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $450.00 K(+50.0%) | $810.00 K(+125.0%) |
Mar 2024 | - | $300.00 K(+400.0%) | $360.00 K(+500.0%) |
Dec 2023 | $60.00 K(-86.7%) | $60.00 K(-86.7%) | $60.00 K(-91.5%) |
Dec 2022 | $450.00 K(-26.7%) | $450.00 K(+336.9%) | $702.00 K(+41.5%) |
June 2022 | - | $103.00 K(-30.9%) | $496.00 K(-12.5%) |
Mar 2022 | - | $149.00 K(-2.0%) | $567.00 K(-7.7%) |
Dec 2021 | $614.00 K(-23.2%) | $152.00 K(+65.2%) | $614.00 K(-6.5%) |
Sept 2021 | - | $92.00 K(-47.1%) | $657.00 K(-14.6%) |
June 2021 | - | $174.00 K(-11.2%) | $769.00 K(-5.8%) |
Mar 2021 | - | $196.00 K(+0.5%) | $816.00 K(+2.1%) |
Dec 2020 | $799.00 K(-0.9%) | $195.00 K(-4.4%) | $799.00 K(+7.4%) |
Sept 2020 | - | $204.00 K(-7.7%) | $744.00 K(-2.6%) |
June 2020 | - | $221.00 K(+23.5%) | $764.00 K(-11.3%) |
Mar 2020 | - | $179.00 K(+27.9%) | $861.00 K(+6.8%) |
Dec 2019 | $806.00 K(+45.0%) | $140.00 K(-37.5%) | $806.00 K(+0.6%) |
Sept 2019 | - | $224.00 K(-29.6%) | $801.00 K(+22.7%) |
June 2019 | - | $318.00 K(+156.5%) | $653.00 K(+5.3%) |
Mar 2019 | - | $124.00 K(-8.1%) | $620.00 K(+11.5%) |
Dec 2018 | $556.00 K(-41.1%) | $135.00 K(+77.6%) | $556.00 K(+5.9%) |
Sept 2018 | - | $76.00 K(-73.3%) | $525.00 K(-21.9%) |
June 2018 | - | $285.00 K(+375.0%) | $672.00 K(-1.2%) |
Mar 2018 | - | $60.00 K(-42.3%) | $680.00 K(-28.0%) |
Dec 2017 | $944.00 K(-18.6%) | $104.00 K(-53.4%) | $944.00 K(-20.1%) |
Sept 2017 | - | $223.00 K(-23.9%) | $1.18 M(-17.5%) |
June 2017 | - | $293.00 K(-9.6%) | $1.43 M(+7.9%) |
Mar 2017 | - | $324.00 K(-5.0%) | $1.33 M(+14.4%) |
Dec 2016 | $1.16 M(-14.1%) | $341.00 K(-27.9%) | $1.16 M(+26.1%) |
Sept 2016 | - | $473.00 K(+151.6%) | $919.00 K(+18.9%) |
June 2016 | - | $188.00 K(+19.7%) | $773.00 K(-41.8%) |
Mar 2016 | - | $157.00 K(+55.4%) | $1.33 M(-26.9%) |
Dec 2015 | $1.35 M(-51.8%) | $101.00 K(-69.1%) | $1.82 M(-29.4%) |
Sept 2015 | - | $327.00 K(-56.0%) | $2.57 M(-10.6%) |
June 2015 | - | $744.00 K(+15.3%) | $2.88 M(+1.6%) |
Mar 2015 | - | $645.00 K(-24.6%) | $2.83 M(+1.1%) |
Dec 2014 | $2.80 M(-25.9%) | $856.00 K(+35.4%) | $2.80 M(+41.8%) |
Sept 2014 | - | $632.00 K(-9.6%) | $1.97 M(+0.2%) |
June 2014 | - | $699.00 K(+14.0%) | $1.97 M(-33.8%) |
Mar 2014 | - | $613.00 K(+1943.3%) | $2.98 M(-30.9%) |
Dec 2013 | $3.78 M | $30.00 K(-95.2%) | $4.31 M(-9.1%) |
Sept 2013 | - | $629.00 K(-63.1%) | $4.74 M(-0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2013 | - | $1.71 M(-12.2%) | $4.79 M(+19.6%) |
Mar 2013 | - | $1.94 M(+320.6%) | $4.00 M(-90.3%) |
Dec 2012 | $41.38 M(+2803.9%) | $462.00 K(-31.5%) | $41.38 M(+0.1%) |
Sept 2012 | - | $674.00 K(-27.0%) | $41.36 M(+0.5%) |
June 2012 | - | $923.00 K(-97.7%) | $41.15 M(+1.8%) |
Mar 2012 | - | $39.32 M(+8857.2%) | $40.42 M(+2736.6%) |
Dec 2011 | $1.43 M(+218.1%) | $439.00 K(-6.4%) | $1.43 M(+29.7%) |
Sept 2011 | - | $469.00 K(+145.5%) | $1.10 M(+62.6%) |
June 2011 | - | $191.00 K(-41.4%) | $676.00 K(+13.8%) |
Mar 2011 | - | $326.00 K(+188.5%) | $594.00 K(+32.6%) |
Dec 2010 | $448.00 K(-68.6%) | $113.00 K(+145.7%) | $448.00 K(-17.0%) |
Sept 2010 | - | $46.00 K(-57.8%) | $540.00 K(-51.1%) |
June 2010 | - | $109.00 K(-39.4%) | $1.10 M(-17.8%) |
Mar 2010 | - | $180.00 K(-12.2%) | $1.34 M(-5.7%) |
Dec 2009 | $1.43 M(-8.4%) | $205.00 K(-66.4%) | $1.43 M(-12.0%) |
Sept 2009 | - | $611.00 K(+75.6%) | $1.62 M(+19.1%) |
June 2009 | - | $348.00 K(+33.3%) | $1.36 M(-3.8%) |
Mar 2009 | - | $261.00 K(-34.6%) | $1.41 M(-9.2%) |
Dec 2008 | $1.55 M(-7.6%) | $399.00 K(+13.7%) | $1.55 M(-23.9%) |
Sept 2008 | - | $351.00 K(-12.5%) | $2.04 M(+9.1%) |
June 2008 | - | $401.00 K(-0.7%) | $1.87 M(+12.9%) |
Mar 2008 | - | $404.00 K(-54.5%) | $1.66 M(-1.5%) |
Dec 2007 | $1.68 M(-63.3%) | $888.00 K(+393.3%) | $1.68 M(+46.1%) |
Sept 2007 | - | $180.00 K(-3.7%) | $1.15 M(-17.4%) |
June 2007 | - | $187.00 K(-56.4%) | $1.40 M(-27.9%) |
Mar 2007 | - | $429.00 K(+20.2%) | $1.94 M(-57.8%) |
Dec 2006 | $4.59 M(+65.0%) | $357.00 K(-15.6%) | $4.59 M(-5.7%) |
Sept 2006 | - | $423.00 K(-41.9%) | $4.87 M(-4.2%) |
June 2006 | - | $728.00 K(-76.4%) | $5.08 M(-1.5%) |
Mar 2006 | - | $3.08 M(+384.4%) | $5.16 M(+85.6%) |
Dec 2005 | $2.78 M(-24.4%) | $636.10 K(0.0%) | $2.78 M(-9.3%) |
Sept 2005 | - | $636.10 K(-21.2%) | $3.06 M(-8.5%) |
June 2005 | - | $807.50 K(+15.1%) | $3.35 M(-3.2%) |
Mar 2005 | - | $701.40 K(-23.7%) | $3.46 M(-5.9%) |
Dec 2004 | $3.68 M(+54.3%) | $919.60 K(0.0%) | $3.68 M(+33.3%) |
Sept 2004 | - | $919.60 K(0.0%) | $2.76 M(+50.0%) |
June 2004 | - | $919.60 K(0.0%) | $1.84 M(+100.0%) |
Mar 2004 | - | $919.60 K | $919.60 K |
Dec 2003 | $2.38 M(+19.8%) | - | - |
Dec 2002 | $1.99 M | - | - |
FAQ
- What is Yield10 Bioscience annual revenue?
- What is the all time high annual revenue for Yield10 Bioscience?
- What is Yield10 Bioscience annual revenue year-on-year change?
- What is Yield10 Bioscience quarterly revenue?
- What is the all time high quarterly revenue for Yield10 Bioscience?
- What is Yield10 Bioscience TTM revenue?
- What is the all time high TTM revenue for Yield10 Bioscience?
What is Yield10 Bioscience annual revenue?
The current annual revenue of YTEN is $60.00 K
What is the all time high annual revenue for Yield10 Bioscience?
Yield10 Bioscience all-time high annual revenue is $41.38 M
What is Yield10 Bioscience annual revenue year-on-year change?
Over the past year, YTEN annual revenue has changed by -$390.00 K (-86.67%)
What is Yield10 Bioscience quarterly revenue?
The current quarterly revenue of YTEN is $450.00 K
What is the all time high quarterly revenue for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly revenue is $39.32 M
What is Yield10 Bioscience TTM revenue?
The current TTM revenue of YTEN is $810.00 K
What is the all time high TTM revenue for Yield10 Bioscience?
Yield10 Bioscience all-time high TTM revenue is $41.38 M